Francesca Dibiase Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 150 Pierce St, Somerset, NJ 08873 Phone: 888-319-1818 |
Devaki S Balepur, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2013 State Route 27 # 1, Somerset, NJ 08873 Phone: 732-951-1002 |
Mr. Leonard Weinfeld, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 390 Windfall Ln, Somerset, NJ 08873 Phone: 732-356-3455 Fax: 732-356-0036 |
Ratnesh Kaur Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 773 Hamilton St, Somerset, NJ 08873 Phone: 732-545-2299 |
Disha Mehta Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 150 Pierce St, Somerset, NJ 08873 Phone: 888-319-1818 |
Deepa Brahmabhatt, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 150 Pierce St, Somerset, NJ 08873 Phone: 908-389-1818 |
News Archive
The Catholic Health Association applauds the U.S. House of Representatives and President Obama for enacting health care reform legislation that will bring security and health to millions of American families. The reform law will save and improve lives across our country. It represents great progress in the long effort to make health care available and affordable to everyone in the United States.
Though a variety of immunotherapy-based strategies are being used against cancer, they are often hindered by the inability of the immune response to enter the immunosuppressive tumor microenvironment and to effectively mount a response to cancer cells.
A group of researchers recently expanded upon the limited prior research examining the effects of soy and whey protein supplementation on testosterone, sex hormone binding globulin (SHBG), and cortisol responses to an acute bout of resistance exercise.
The economic cost of methamphetamine use in the United States reached $23.4 billion in 2005, including the burden of addiction, premature death, drug treatment and many other aspects of the drug, according to a new RAND Corporation study.
Inova Labs, a privately held medical device company focused on developing innovative products for the Chronic Obstructive Pulmonary Disease (COPD) market, announced today that it has secured a Series B round of equity financing for up to $17.5M from an investment syndicate led by Latterell Venture Partners, based in San Francisco, Calif.
› Verified 1 days ago